A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography

ConditionAmyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorMayo Clinic

About this trial

This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance elastography (MRE) in patients with cardiac amyloidosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult, age 20 and greater

Subject is clinically stable without cardiovascular-related hospitalizations within 2 weeks prior to enrollment as assessed by the investigators

Subject is able to provide written informed consent and is willing and able to complete study procedures

Disqualifiers

None

Trial population

Participants will be recruited from the Mayo Clinic's Cardiology, Hematology, and Cardiovascular Imaging clinics."

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Magnetic Resonance Elastography (MRE)

    Diagnostic test

    Patients will undergo a cardiac MRI with the addition of continuous free-breathing and breath-held MRE sequences.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Cardiac Amyloidosis1 intervention

Trial outcomes

Primary outcomes

1

Percentage of subjects able to complete a Magnetic Resonance Elastography exam

Magnetic Resonance Elastography exam completion will be determined by signal to noise (SNR) ratio

Time frame
Baseline
2

Mean Myocardial Stiffness

Mean Myocardial stiffness will be measured by magnetic resonance elastography during early systole, end systole, early diastole and end diastole (kPa).

Time frame
Baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.